From: Associations between HLA and autoimmune neurological diseases with autoantibodies
Autoantibody | HLA | Population | References |
---|---|---|---|
Anti-Hu | DQB1*02-DRB1*03 | SCLC-PNS | [23] |
Anti-Yo | DQA1*01:03-DQB1*06:03-DRB1*13:01 | Ovarian cancer | [29] |
Anti-VGCC | B*08:01 | Non-paraneoplastic LEMS (69%) | [37] |
Anti-AchR | B*08:01 | EOMG | |
DQB1*05-DRB1*16 | LOMG | ||
DRB1*15 | LOMG | ||
DQA1*03-DQB1*03-DRB1*09 | EOMG | [55] | |
DQA1*03-DQB1*06-DRB1*13 | EOMG | [55] | |
DRB1*04:04 | Pre-pubertal EOMG | [41] | |
Anti-NMDAR | DRB1*16:02 | Â | [96] |
B*07:02 | Adult onset | [95] | |
Anti-GAD | DQB1*02-DRB1*03 | SPS & CA | |
Anti-AQP4 | DRB1*03 | Caucasian and mixed | |
DPB1*05:01 | East Asia | ||
DRB1*16:02 | East Asia |